Hopp til hovedinnhold

Hyperaldosteronisme

Hyperaldosteronisme er en tilstand der kroppen produserer for mye av hormonet aldosteron. Dette fører til høyt blodtrykk, og hos mange lavt kaliuminnhold i blodet.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hormoner-og-naring/binyresykdommer/hyperaldosteronisme/ 

Hva er aldosteron?

Hyperaldosteronisme

Årsaker

Diagnostikk

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Hyperaldosteronisme. Referanselisten for dette dokumentet vises nedenfor.

  1. Grytaas MA, Bakke Å, Ueland GÅ, Jørgensen AP. Primær hyperaldosteronisme. Nasjonal veileder i endokrinologi. Versjon 2.8, publisert 15.12.2020. Siden lest 04.01.2021 www.prosedyrer.no 
  2. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101:1889. PubMed 
  3. Brown JM, Siddiqui M, Calhoun DA, et al. The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study. Ann Intern Med 2020; 173: 10-20. pmid:32449886 PubMed 
  4. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045. PubMed 
  5. Stowasser M. Primary Aldosteronism: Rare bird or common cause of secondary hypertension?. Curr Hypertens Rep 2001; 3: 230. PubMed 
  6. Hung A, Ahmed S, Gupta A, et al. Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism. J Clin Endocrinol Metab 2021; 106: 2423-35. pmid:34008000 PubMed 
  7. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709. New England Journal of Medicine 
  8. Pitt B, Remme W, Zannad F, Neaton J. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309. New England Journal of Medicine 
  9. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689-99. pmid:28576687 PubMed 
  10. Chen Y-Y, Lin Y-HH, Huang W-C, et al. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc 2019; 3: 1110-26. pmid:31086833 PubMed 
  11. Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2018; 6: 41-50. pmid:29129575 PubMed 
  12. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003; 21: 2149-57. 14597859
  13. Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295: 2638-45. PubMed